Patient preferences for colon cancer screening
- 1 July 1999
- journal article
- research article
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 14 (7) , 432-437
- https://doi.org/10.1046/j.1525-1497.1999.00018.x
Abstract
OBJECTIVE: To measure patient preferences for four different screening strategies: annual fecal occult blood testing (FOBT) alone; flexible sigmoidoscopy (FSIG) every 5 years alone; both annual FOBT and FSIG every 5 years; or no screening. DESIGN: Survey. SETTING: University internal medicine clinic. PATIENTS: Convenience sample of 146 adults (aged 50–75 years) with no previous history of colon cancer. INTERVENTION: Three-part educational program on colon cancer screening administered verbally by trained research assistants. MEASUREMENTS AND MAIN RESULTS: Patient preferences for screening were measured at three points: after descriptive information about colon cancer and screening options (testing procedure information); after information about test performance but with no out-of-pocket costs (test performance information); and finally with hypothetical out-of-pocket costs (cost information). After only descriptive test information, the most popular strategies were FOBT alone (45%) or both tests (38%). Fewer patients preferred FSIG alone (13%). After information about test performance, more subjects preferred both tests (47%), and fewer subjects preferred FOBT alone (36%) (p=.12). With hypothetical out-of-pocket costs, the proportion preferring FOBT alone increased to 53%, while those preferring both tests decreased to 31% (p<.001). Less than 5% of patients preferred no screening. CONCLUSIONS: Patient preferences for colon cancer screening were modestly sensitive to information about test performance and strongly sensitive to out-of-pocket costs. The heterogeneity of patients’ preferences for how to be screened supports informed shared decision making as a possible means of improving colon cancer screening.Keywords
This publication has 11 references indexed in Scilit:
- Sharing decisions with patients: is the information good enough?BMJ, 1999
- Shared decision-making in the medical encounter: What does it mean? (or it takes at least two to tango)Social Science & Medicine, 1997
- Colorectal cancer screening: Clinical guidelines and rationaleGastroenterology, 1997
- Randomised study of screening for colorectal cancer with faecal-occult-blood testThe Lancet, 1996
- Randomised controlled trial of faecal-occult-blood screening for colorectal cancerThe Lancet, 1996
- The importance of patient preference in the decision to screen for prostate cancerJournal of General Internal Medicine, 1996
- Screening for colorectal cancer--United States, 1992-1993, and new guidelines.1996
- Reducing Mortality from Colorectal Cancer by Screening for Fecal Occult BloodNew England Journal of Medicine, 1993
- A Case–Control Study of Screening Sigmoidoscopy and Mortality from Colorectal CancerNew England Journal of Medicine, 1992
- Patients’ participation in medical careJournal of General Internal Medicine, 1988